When Kate Fu revamped ME 231: Geometric Modeling for Design and Manufacturing, she knew the new hands-on drawing exercises would take many students out of their comfort zones. After all,…
Five years after graduating from the University of Wisconsin-Madison, Matt Knoespel and Phil Terrien are co-founders and the engineering backbone of a medical device company that’s collected a slew of…
Over the course of three years spent working on the same research project, University of Wisconsin-Madison undergraduate Katherine Breen made a fundamental self-discovery that went beyond any data she’ll publish….
Gene therapies have the potential to treat neurological disorders like Alzheimer’s and Parkinson’s diseases, but they face a common barrier — the blood-brain barrier. Now, researchers at the University of…
An interdisciplinary research initiative led by the University of Wisconsin-Madison is emerging as a global leader in developing better technologies for detecting and preventing concussions and other traumatic brain injuries….
University of Wisconsin-Madison industrial engineering students Rayne Wolf, Josie Beres and Greyson Wainwright huddle around a desktop hydroponic system, inspecting the growth of alfalfa, mung beans and soybeans. Later in…
In late 2019, staff at Beloit, Wisconsin-based company NorthStar Medical Radioisotopes opened a package filled with radioactive materials. The delivery sparked an ongoing research collaboration with the University of Wisconsin-Madison…
Researchers at the University of Wisconsin–Madison are developing the means to turn stem cells into a wide range of specific types of spinal cord neurons and cells in the hindbrain—the…
In the wake of a spinal cord injury, a protective scar forms to allow the central nervous system to heal. It’s not unlike the body’s reaction to a run of…
Chimeric antigen receptor (CAR) T cells are biological assassins: white blood cells that are specifically engineered to attack cancer cells. Over the past five years, they’ve become an established therapeutic…
In a July 2022 opinion piece in Scientific American, Vilas Distinguished Achievement Professor in chemical and biological engineering John Yin discusses the potential for using zombie viral particles to reduce…